Results 21 to 30 of about 4,911,014 (257)

Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study

Breast, 2021
Aim: To evaluate pharmacokinetics, efficacy and safety of fixed-dose combination (FDC) of oral capecitabine + cyclophosphamide in metastatic breast cancer (MBC) patients progressing after anthracycline and/or taxane chemotherapy.
Sudeep Gupta, Ghanashyam Biswas, Suresh Babu, Tanveer M. Maksud, Kuntegowdennahalli C. Lakshmaiah, Jayanti G. Patel, Gopal Raja, Rakesh R. Boya, Pramod Patil, Kakali Choudhury, Shailesh A. Bondarde, Rakesh S. Neve, Guruprasad Bhat, Gopichand Mamillapalli, Apurva A. Patel, Piyush Patel, Nisarg Joshi, Vinay Bajaj, Mujtaba A. Khan   +18 more
doaj   +1 more source

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations

Chinese Medical Journal, 2015
Background: Decreases in the bioavailability of rifampicin (RFP) can lead to the development of drug resistance and treatment failure. Therefore, we investigated the relative bioavailability of RFP from one four-drug fixed-dose combination (FDC ...
Hui Zhu, Shao-Chen Guo, Lan-Hu Hao, Cheng-Cheng Liu, Bin Wang, Lei Fu, Ming-Ting Chen, Lin Zhou, Jun-Ying Chi, Wen Yang, Wen-Juan Nie, Yu Lu   +11 more
doaj   +1 more source

Treatment outcome in smear-positive pulmonary tuberculosis patients treated with a fixed-dose drug combination regimen in comparison with a separate regimen: a randomized clinical trial

Egyptian Journal of Chest Disease and Tuberculosis, 2021
Context The number of tuberculosis (TB) patients and multidrug-resistant species of Mycobacterium tuberculosis are increasing worldwide. Effective treatment is still the key factor to control TB in the society.
Seyed Saeed Hashemi Nazari, Saeid Fallah, Vahideh Raeisi   +2 more
doaj   +1 more source

Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD [PDF]

, 2015
Sanjeevan Muruganandan,1 Lata Jayaram2,3 1Department of Respiratory and Sleep Medicine, Austin Health, 2Department of Respiratory and Sleep Medicine, Western Health, 3University of Melbourne, Melbourne, Victoria, Australia Abstract: Chronic obstructive
Muruganandan, S, Muruganandan S, Jayaram L, Jayaram, L   +3 more
core   +1 more source

Prevalence of pregabalin prescribing trends from various outpatient department: A prospective observational study from a tertiary care teaching hospital at South India

National Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: We assessed utilization patterns, profile of diagnoses, and fixed dose combination (FDC) with pregabalin in patients with various indications.
Kanagasanthosh K, Saravana K S, Indra A
doaj   +1 more source

A promising choice in hypertension treatment: Fixed-dose combinations

Asian Journal of Pharmaceutical Sciences, 2014
Obtaining the target blood pressure level by monotherapy can be challenging currently, especially for the patients who are suffering from other diseases meanwhile.
Xinhuan Wan, Panqin Ma, Xiangrong Zhang
doaj   +1 more source

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation [PDF]

, 2011
Background Although patients have more problems using metered dose inhalers, clinical comparisons suggest they provide similar control to dry powder inhalers.
Eszes, Noemi, Gabriele Nicolini, Chrystyn, Henry, Eszes Noemi, György Losonczy, Noemi Eszes, Henry Chrystyn, Müller, Veronika, Gabriella Gálffy, Chrystyn Henry, Nicolini Gabriele, Gálffy Gabriella, Andrea Bizzi, Lilla Tamási, Bizzi Andrea, Tamási Lilla, Gálffy, Gabriella, Tamási, Lilla, Müller Veronika, Losonczy, György, Nicolini, Gabriele, Bizzi, Andrea, Veronika Müller, Losonczy György   +23 more
core   +2 more sources

History of combined protection: 25 years of using the fixed-dose combination of amlodipine and bisoprolol in clinical practice

, 2022
The paper discusses the role of Concor AM, the fixed-dose combination of amlodipine and bisoprolol, which has been used in clinical practice for treatment of patients with cardiovascular diseases for 25 years.
Sergey R. Gilyarevsky, Irina M. Kuzmina, Nana G. Bendeliani, Maria V. Golshmid   +3 more
core   +1 more source

Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Acta Medica Indonesiana, 2017
Background: a patient with a history of tuberculosis (TB) has a risk up to 27% to develop recurrence within 2 years after being cured. Indonesia itself has more than 7,500 recurrent cases annually, regardless of reinfection or relapse.
Arvin Pramudita, Cleopas M Rumende, Ardi Findyartini   +2 more
doaj   +2 more sources

DRESS syndrome: a case report

MGM Journal of Medical Sciences, 2021
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare adverse drug reaction. We report a rare case of DRESS syndrome secondary to antitubercular treatment (ATT).
Shreya Gudi, Tushar Kanti Biswas, Sriraj Kane   +2 more
doaj   +1 more source